Unliganded progesterone receptormediated targeting of an RNA-containing repressive complex silences a subset of hormone-inducible genes

Genes and Development

Volumn 27, Issue 10, 2013, Pages 1179-1197

  Vicent, Guillermo Pablo ^a,b   Nacht, A Silvina ^a,b   Zaurin, Roser ^a,b   Font Mateu, Jofre ^a,b   Soronellas, Daniel ^a,b   Le Dily, Francois ^a,b   Reyes, Diana ^a,b   Beato, Miguel ^a,b  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Basal repression; Cell proliferation; Progesterone gene regulation; RNA containing repressive complex; Unliganded receptor

Indexed keywords

HETEROCHROMATIN PROTEIN 1; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HORMONE; PROGESTERONE RECEPTOR; RNA; CBX3 PROTEIN, HUMAN; HISTONE; HISTONE DEMETHYLASE; KDM1A PROTEIN, HUMAN; LIGAND; LONG UNTRANSLATED RNA; MITOGEN AND STRESS ACTIVATED PROTEIN KINASE 1; MITOGEN AND STRESS-ACTIVATED PROTEIN KINASE 1; MULTIPROTEIN COMPLEX; NONHISTONE PROTEIN; PROGESTERONE; S6 KINASE; STEROID RECEPTOR RNA ACTIVATOR;

ARTICLE; BREAST CANCER; CANCER CELL; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; BASAL REPRESSION; BINDING SITE; BREAST TUMOR; CELL PROLIFERATION; CHEMISTRY; CHROMATIN; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; METABOLISM; MOUSE MAMMARY TUMOR ONCOVIRUS; PATHOLOGY; PHOSPHORYLATION; PROGESTERONE GENE REGULATION; RNA-CONTAINING REPRESSIVE COMPLEX; TUMOR CELL LINE; UNLIGANDED RECEPTOR;

BASAL REPRESSION; CELL PROLIFERATION; PROGESTERONE GENE REGULATION; RNA-CONTAINING REPRESSIVE COMPLEX; UNLIGANDED RECEPTOR;

BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN; CHROMOSOMAL PROTEINS, NON-HISTONE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENOME, HUMAN; HISTONE DEMETHYLASES; HISTONES; HUMANS; LIGANDS; MAMMARY TUMOR VIRUS, MOUSE; MULTIPROTEIN COMPLEXES; PHOSPHORYLATION; PROGESTERONE; RECEPTORS, PROGESTERONE; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; RNA, LONG UNTRANSLATED;

MLCS; MLOWN;

EID: 84877956152     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.215293.113     Document Type: Article

References (81)

1. Akhtar A., Zink D, Becker PB. 2000. Chromodomains are protein-RNA interaction modules. Nature 407: 405-409.
2. Archer T.K., Lefebvre P, Wolford RG, Hager GL. 1992. Transcription factor loading on the MMTV promoter: A bimodal mechanism for promoter activation. Science 255: 1573-1576.
3. Ayoub N., Jeyasekharan AD, Bernal JA, Venkitaraman AR. 2008. HP1-b mobilization promotes chromatin changes that initiate the DNA damage response. Nature 453: 682-686.
4. Ballare C., Castellano G, Gaveglia L, Althammer S, Gonzalez-Vallinas J., Eyras E, Le Dily F, Zaurin R, Soronellas D, Vicent GP, et al. 2013. Nucleosome-driven transcription factor binding and gene regulation. Mol Cell 49: 67-79.
5. Bannister A.J., Kouzarides T. 2011. Regulation of chromatin by histone modifications. Cell Res 21: 381-395.
6. Bannister A.J., Zegerman P, Partridge JF, Miska EA, Thomas JO, Allshire R.C., Kouzarides T. 2001. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410: 120-124.
7. Barrett A., Madsen B, Copier J, Lu PJ, Cooper L, Scibetta AG, Burchell J., Taylor-Papadimitriou J. 2002. PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: A new cancer/ testis antigen? Int J Cancer 101: 581-588.
8. Beato M., Vicent GP. 2011. When every minute counts: The enzymatic complexity associated with the activation of hormone-dependent genes. Cell Cycle 10: 2407-2409.
9. Beato M., Vicent GP. 2012. Impact of chromatin structure and dynamics on PR signaling. The initial steps in hormonal gene regulation. Mol Cell Endocrinol 357: 37-42.
10. Bruggemeier U., Rogge L, Winnacker EL, Beato M. 1990. Nuclear factor I acts as a transcription factor on the MMTV promoter but competes with steroid hormone receptors for DNA binding. EMBO J 9: 2233-2239.
11. Chalepakis G., Arnemann J, Slater E, Bruller HJ, Gross B, Beato M. 1988. Differential gene activation by glucocorticoids and progestins through the hormone regulatory element of mouse mammary tumor virus. Cell 53: 371-382.
12. Colley S.M., Leedman PJ. 2009. SRA and its binding partners: An expanding role for RNA-binding coregulators in nuclear receptor-mediated gene regulation. Crit Rev Biochem Mol Biol 44: 25-33.
13. Colley S.M., Leedman PJ. 2011. Steroid receptor RNA activator-A nuclear receptor coregulator with multiple partners: Insights and challenges. Biochimie 93: 1966-1972.
14. Daujat S., Zeissler U, Waldmann T, Happel N, Schneider R. 2005. HP1 binds specifically to Lys26-methylated histone H1.4, whereas simultaneous Ser27 phosphorylation blocks HP1 binding. J Biol Chem 280: 38090-38095.
15. Eissenberg J.C., Shilatifard A. 2006. Leaving a mark: The many footprints of the elongating RNA polymerase II. Curr Opin Genet Dev 16: 184-190.
16. Emberley E., Huang GJ, Hamedani MK, Czosnek A, Ali D, Grolla A, Lu B, Watson PH, Murphy LC, Leygue E. 2003. Identification of new human coding steroid receptor RNA activator isoforms. Biochem Biophys Res Commun 301: 509-515.
17. Fischle W., Tseng BS, Dormann HL, Ueberheide BM, Garcia BA, Shabanowitz J., Hunt DF, Funabiki H, Allis CD. 2005. Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation. Nature 438: 1116-1122.
18. Foulds C.E., Tsimelzon A, Long W, Le A, Tsai SY, Tsai MJ, O'Malley BW. 2010. Research resource: Expression profiling reveals unexpected targets and functions of the human steroid receptor RNA activator (SRA) gene. Mol Endocrinol 24: 1090-1105.
19. Gupta R.A., Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai M.C., Hung T, Argani P, Rinn JL, et al. 2010. Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464: 1071-1076.
20. Guttman M., Donaghey J, Carey BW, Garber M, Grenier JK, Munson G., Young G, Lucas AB, Ach R, Bruhn L, et al. 2011. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477: 295-300.
21. Hakimi M.A., Bochar DA, Chenoweth J, Lane WS, Mandel G, Shiekhattar R. 2002. A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes. Proc Natl Acad Sci 99: 7420-7425.
22. Hatchell E.C., Colley SM, Beveridge DJ, Epis MR, Stuart LM, Giles K.M., Redfern AD, Miles LE, Barker A, MacDonald LM, et al. 2006. SLIRP, a small SRA binding protein, is a nuclear receptor corepressor. Mol Cell 22: 657-668.
23. Hiragami-Hamada K, Shinmyozu K, Hamada D, Tatsu Y, Uegaki K, Fujiwara S, Nakayama J. 2011. N-terminal phosphorylation of HP1a promotes its chromatin binding. Mol Cell Biol 31: 1186-1200.
24. Horwitz K.B., Tung L, Takimoto GS. 1995. Novel mechanisms of antiprogestin action. J Steroid Biochem Mol Biol 53: 9-17.
25. Huarte M., Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M, et al. 2010. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142: 409-419.
26. Hube F., Velasco G, Rollin J, Furling D, Francastel C. 2011. Steroid receptor RNA activator protein binds to and counteracts SRA RNA-mediated activation of MyoD and muscle differentiation. Nucleic Acids Res 39: 513-525.
27. Hynes N., van Ooyen AJ, Kennedy N, Herrlich P, Ponta H, Groner B. 1983. Subfragments of the large terminal repeat cause glucocorticoid-responsive expression of mouse mammary tumor virus and of an adjacent gene. Proc Natl Acad Sci 80: 3637-3641.
28. Jacobs S.A., Taverna SD, Zhang Y, Briggs SD, Li J, Eissenberg JC, Allis C.D., Khorasanizadeh S. 2001. Specificity of the HP1 chromo domain for the methylated N-terminus of histone H3. EMBO J 20: 5232-5241.
29. Jenuwein T., Allis CD. 2001. Translating the histone code. Science 293: 1074-1080.
30. Kino T., Hurt DE, Ichijo T, Nader N, Chrousos GP. 2010. Noncoding RNA gas5 is a growth arrest-and starvation-associated repressor of the glucocorticoid receptor. Sci Signal 3: ra8.
31. Kirschmann D.A., Lininger RA, Gardner LM, Seftor EA, Odero VA, Ainsztein AM, Earnshaw WC, Wallrath LL, Hendrix MJ. 2000. Down-regulation of HP1Hsa expression is associated with the metastatic phenotype in breast cancer. Cancer Res 60: 3359-3363.
32. Ko M.S., Nakauchi H, Takahashi N. 1990. The dose dependence of glucocorticoid-inducible gene expression results from changes in the number of transcriptionally active templates. EMBO J 9: 2835-2842.
33. Kouzarides T. 2007. Chromatin modifications and their function. Cell 128: 693-705.
34. Krishnakumar R., Kraus WL. 2010. PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. Mol Cell 39: 736-749.
35. Kurokawa R. 2011. Long noncoding RNA as a regulator for transcription. Prog Mol Subcell Biol 51: 29-41.
36. Lachner M., O'Carroll D, Rea S, Mechtler K, Jenuwein T. 2001. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410: 116-120.
37. Langmead B., Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
38. Lanz R.B., McKenna NJ, Onate SA, Albrecht U, Wong J, Tsai SY, Tsai M.J., O'Malley BW. 1999. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97: 17-27.
39. Lee M.G., Wynder C, Bochar DA, Hakimi MA, Cooch N, Shiekhattar R. 2006. Functional interplay between histone demethylase and deacetylase enzymes. Mol Cell Biol 26: 6395-6402.
40. Lee S.W., Cho YS, Na JM, Park UH, Kang M, Kim EJ, Um SJ. 2010. ASXL1 represses retinoic acid receptor-mediated transcription through associating with HP1 and LSD1. J Biol Chem 285: 18-29.
41. Leygue E. 2007. Steroid receptor RNA activator (SRA1): Unusual bifaceted gene products with suspected relevance to breast cancer. Nucl Recept Signal 5: e006.
42. Lim S., Janzer A, Becker A, Zimmer A, Schule R, Buettner R, Kirfel J. 2010. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 31: 512-520.
43. Liu J., Xiao N, DeFranco DB. 1999. Use of digitonin-permeabilized cells in studies of steroid receptor subnuclear trafficking. Methods 19: 403-409.
44. Lomberk G., Bensi D, Fernandez-Zapico ME, Urrutia R. 2006. Evidence for the existence of an HP1-mediated subcode within the histone code. Nat Cell Biol 8: 407-415.
45. Lonard D.M., O'Malley BW. 2007. Nuclear receptor coregulators: Judges, juries, and executioners of cellular regulation. Mol Cell 27: 691-700.
46. Lu P.J., Sundquist K, Baeckstrom D, Poulsom R, Hanby A, Meier-Ewert S., Jones T, Mitchell M, Pitha-Rowe P, Freemont P, et al. 1999. A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically upregulated in breast cancer. J Biol Chem274: 15633-15645.
47. Lu B.Y., Emtage PC, Duyf BJ, Hilliker AJ, Eissenberg JC. 2000. Heterochromatin protein 1 is required for the normal expression of two heterochromatin genes in Drosophila. Genetics 155: 699-708.
48. Luger K., Mader AW, Richmond RK, Sargent DF, Richmond TJ. 1997. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389: 251-260.
49. Maison C., Bailly D, Peters AH, Quivy JP, Roche D, Taddei A, Lachner M., Jenuwein T, Almouzni G. 2002. Higher-order structure in pericentric heterochromatin involves a distinct pattern of histone modification and an RNA component. Nat Genet 30: 329-334.
50. Mariner P.D., Walters RD, Espinoza CA, Drullinger LF, Wagner SD, Kugel JF, Goodrich JA. 2008. Human Alu RNA is a modular transacting repressor of mRNA transcription during heat shock. Mol Cell 29: 499-509.
51. Mateescu B., England P, Halgand F, Yaniv M, Muchardt C. 2004. Tethering of HP1 proteins to chromatin is relieved by phosphoacetylation of histone H3. EMBO Rep 5: 490-496.
52. Metzger E., Wissmann M, Yin N, Muller JM, Schneider R, Peters AH, Gunther T, Buettner R, Schule R. 2005. LSD1 demethylates repressive histone marks to promote androgen-receptordependent transcription. Nature 437: 436-439.
53. Migliaccio A., Piccolo D, Castoria G, Di Domenico M, Bilancio A, Lombardi M., Gong W, Beato M, Auricchio F. 1998. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J 17: 2008-2018.
54. Muchardt C., Guilleme M, Seeler JS, Trouche D, Dejean A, Yaniv M. 2002. Coordinated methyl and RNA binding is required for heterochromatin localization of mammalian HP1a. EMBO Rep 3: 975-981.
55. Nielsen P.R., Nietlispach D, Mott HR, Callaghan J, Bannister A, Kouzarides T., Murzin AG, Murzina NV, Laue ED. 2002. Structure of the HP1 chromodomain bound to histone H3 methylated at lysine 9. Nature 416: 103-107.
56. Niranjanakumari S., Lasda E, Brazas R, Garcia-Blanco MA. 2002. Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo. Methods 26: 182-190.
57. Ooi L., Wood IC. 2007. Chromatin crosstalk in development and disease: Lessons from REST. Nat Rev Genet 8: 544-554.
58. Payvar F., DeFranco D, Firestone GL, Edgar B, Wrange O, Okret S, Gustafsson J.A., Yamamoto KR. 1983. Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region. Cell 35: 381-392.
59. Peters A.H., O'Carroll D, Scherthan H, Mechtler K, Sauer S, Schofer C., Weipoltshammer K, Pagani M, Lachner M, Kohlmaier A., et al. 2001. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107: 323-337.
60. Richard-Foy H, Hager GL. 1987. Sequence-specific positioning of nucleosomes over the steroid-inducible MMTV promoter. EMBO J 6: 2321-2328.
61. Sachs L.M., Jones PL, Havis E, Rouse N, Demeneix BA, Shi YB. 2002. Nuclear receptor corepressor recruitment by unliganded thyroid hormone receptor in gene repression during Xenopus laevis development. Mol Cell Biol 22: 8527-8538.
62. Scheidereit C., Geisse S, Westphal HM, Beato M. 1983. The glucocorticoid receptor binds to defined nucleotide sequences near the promoter of mouse mammary tumour virus. Nature 304: 749-752.
63. Shi Y., Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero R.A. 2004. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119: 941-953.
64. Shi Y.J., Matson C, Lan F, Iwase S, Baba T, Shi Y. 2005. Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell 19: 857-864.
65. Strutt H., Paro R. 1999. Mapping DNA target sites of chromatin proteins in vivo by formaldehyde crosslinking. Methods Mol Biol 119: 455-467.
66. Thornton J.W., Need E, Crews D. 2003. Resurrecting the ancestral steroid receptor: Ancient origin of estrogen signaling. Science 301: 1714-1717.
67. Truss M., Bartsch J, Schelbert A, Hache RJ, Beato M. 1995. Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo. EMBO J 14: 1737-1751.
68. Tsai M.C., Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y., Segal E, Chang HY. 2010. Long noncoding RNA as modular scaffold of histone modification complexes. Science 329: 689-693.
69. Vicent G.P., Ballare C, Nacht AS, Clausell J, Subtil-Rodriguez A, Quiles I., Jordan A, Beato M. 2006. Induction of progesterone target genes requires activation of Erk and Msk kinases and phosphorylation of histone H3. Mol Cell 24: 367-381.
70. Vicent G.P., Zaurin R, Nacht AS, Li A, Font-Mateu J, Le Dily F, Vermeulen M., Mann M, Beato M. 2009. Two chromatin remodeling activities cooperate during activation of hormone responsive promoters. PLoS Genet 5: e1000567.
71. Vicent G.P., Nacht AS, Font-Mateu J, Castellano G, Gaveglia L, Ballare C., Beato M. 2011. Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation. Genes Dev 25: 845-862.
72. Wang K.C., Chang HY. 2011. Molecular mechanisms of long noncoding RNAs. Mol Cell 43: 904-914.
73. Wang J., Scully K, Zhu X, Cai L, Zhang J, Prefontaine GG, Krones A., Ohgi KA, Zhu P, Garcia-Bassets I, et al. 2007. Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 446: 882-887.
74. Wang Q., Li W, Zhang Y, Yuan X, Xu K, Yu J, Chen Z, Beroukhim R, Wang H, Lupien M, et al. 2009. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 138: 245-256.
75. Weston A.D., Blumberg B, Underhill TM. 2003. Active repression by unliganded retinoid receptors in development: Less is sometimes more. J Cell Biol 161: 223-228.
76. Wright R.H., Castellano G, Bonet J, Le Dily F, Font-Mateu J, Ballare C., Nacht AS, Soronellas D, Oliva B, Beato M. 2012. CDK2-dependent activation of PARP-1 is required for hormonal gene regulation in breast cancer cells. Genes Dev 26: 1972-1983.
77. Yamane K., Tateishi K, Klose RJ, Fang J, Fabrizio LA, Erdjument-Bromage H., Taylor-Papadimitriou J, Tempst P, Zhang Y. 2007. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol Cell 25: 801-812.
78. Yao H., Brick K, Evrard Y, Xiao T, Camerini-Otero RD, Felsenfeld G. 2010. Mediation of CTCF transcriptional insulation by DEAD-box RNA-binding protein p68 and steroid receptor RNA activator SRA. Genes Dev 24: 2543-2555.
79. Zhang Y., Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, et al. 2008. Model-based analysis of ChIP-seq (MACS). Genome Biol 9: R137.
80. Zheng Z.Y., Zheng SM, Bay BH, Aw SE, C-L Lin, V. 2008. Antiestrogenic mechanism of unliganded progesterone receptor isoformB in breast cancer cells. Breast Cancer Res Treat 110: 111-125.
81. Zwicker J., Lucibello FC, Jerome V, Brusselbach S, Muller R. 1998. CDF-1 mediated repression of cell cycle genes targets a specific subset of transactivators. Nucleic Acids Res 26: 4926-4932.